Home NDC 55154-5659 Doxazosin
Product NDC 55154-5659
11-digit product format 551545659
Labeler code 55154
Product ID 55154-5659_8426eacb-369b-4ecd-a431-aa25ebde34c4
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name doxazosin
Dosage form TABLET
Route ORAL
Labeler Cardinal Health
Application ANDA075509
Marketing category ANDA
Marketing start 2011-08-18
Marketing end 0000-00-00
Substance DOXAZOSIN MESYLATE
Active strength 2 mg/1
Pharmacologic classes Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 55154-5659-0 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 55154-5659-0 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 55154-5659-0 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 55154-5659-0 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 55154-5659-0 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 55154-5659-0 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 55154-5659-0 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 55154-5659-0 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 55154-5659-0 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 55154-5659-0 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 55154-5659-0 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 55154-5659-0 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A075509-001 DOXAZOSIN MESYLATE DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2000-10-19 A075509-002 DOXAZOSIN MESYLATE DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2000-10-19 A075509-003 DOXAZOSIN MESYLATE DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2000-10-19 A075509-004 DOXAZOSIN MESYLATE DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2000-10-19
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A075509-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2000-10-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A075509-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2000-10-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A075509-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2000-10-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A075509-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2000-10-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A075509-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2000-10-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A075509-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2000-10-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A075509-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2000-10-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A075509-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2000-10-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A075509-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2000-10-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A075509-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2000-10-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A075509-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2000-10-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A075509-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2000-10-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A075509-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2000-10-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A075509-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2000-10-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A075509-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2000-10-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A075509-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2000-10-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A075509-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2000-10-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A075509-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2000-10-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A075509-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2000-10-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A075509-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2000-10-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A075509-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2000-10-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A075509-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2000-10-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A075509-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2000-10-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A075509-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2000-10-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A075509-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2000-10-19 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A075509-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2000-10-19 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A075509-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2000-10-19 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A075509-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2000-10-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A075509-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2000-10-19 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A075509-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2000-10-19 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A075509-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2000-10-19 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A075509-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2000-10-19 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A075509-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2000-10-19 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A075509-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2000-10-19 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A075509-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2000-10-19 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A075509-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2000-10-19 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A075509-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2000-10-19 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A075509-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2000-10-19 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A075509-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2000-10-19 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A075509-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2000-10-19 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 92 observed states.
DailyMed Socrata Ingredients# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Doxazosin DOXAZOSIN MESYLATE Aurobindo Pharma Limited 93f2d724-5a54-4721-b04a-e46bc764607b 2024-09-06 Warnings, Adverse reactions Exact identifier application applno (ANDA): 075509 application number: ANDA075509